Overview

A Phase 2 Study to Evaluate Analgesic Effect of IV CR845 For Pain Following Bunionectomy Surgery

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This is a single-center, randomized, double blind, placebo controlled, parallel group proof of concept study to evaluate the analgesic efficacy as well as the safety, tolerability and pharmacokinetic profile of CR845 in patients with pain following bunionectomy surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Cara Therapeutics, Inc.
Treatments:
Analgesics
Peripheral Nervous System Agents